Last summer, the Trump administration announced a voluntary pledge by health insurers to reform prior authorization, but patient advocates and medical providers remain skeptical.

That’s why Ekirch, 31, of Henrico, Virginia, was stunned when she learned Anthem would finally have to pay for life-changing medical treatment. For two years, she had battled the company to cover ...

A national distribution network with robust reach enables broad access to QIVIGY across specialty pharmacies, infusion centers, hospitals, and other sites ...

With a life enriched by the Cuyahoga County Board of Developmental Disabilities, Aaron Oehlstrom is living on his own terms — ...

AOM Infusion ("AOM"), a leading specialty infusion pharmacy and provider, today announced it has joined Kedrion Biopharma’s limited distribution network for QIVIGY®, a new 10% immune globulin (Ig) ...

Kelly for KFF Health News) March 14, 2026 - By Lauren Sausser - Sheldon Ekirch is used to being disappointed by her health insurance company. That’s why Ekirch, 31, of Henrico, Virginia, was stunned ...

This year’s Rare Disease Day event Feb. 27 at the Jacobs School of Medicine and Biomedical Sciences focused on updates in research and diagnostics, and advancements in treatment.

The recent FDA approval of teclistamab (Tecvayli) and daratumumab and hyaluronidase-fihj (Darzelex Faspro) marks a major ...

ADMA Biologics, Inc. (Nasdaq: ADMA) ("ADMA" or the "Company"), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, ...

KORU Medical Systems, Inc. (NASDAQ:KRMD) Q4 2025 Earnings Call Transcript March 12, 2026 KORU Medical Systems, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.02.

Samantha Shenoy, NP, MSN, provides nursing guidance on teclistamab/subcutaneous daratumumab’s second-line approval in multiple myeloma. On March 5, the FDA approved the combination of teclistamab ...